136 related articles for article (PubMed ID: 38118411)
1. Pain management by chemogenetic control of sensory neurons.
Li Y; Ge X; Ji RR
Cell Rep Med; 2023 Dec; 4(12):101338. PubMed ID: 38118411
[TBL] [Abstract][Full Text] [Related]
2. The Antinociceptive and Antiinflammatory Properties of 3-furan-2-yl-N-p-tolyl-acrylamide, a Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptors in Mice.
Bagdas D; Targowska-Duda KM; López JJ; Perez EG; Arias HR; Damaj MI
Anesth Analg; 2015 Nov; 121(5):1369-77. PubMed ID: 26280585
[TBL] [Abstract][Full Text] [Related]
3. Maximizing the effect of an α7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits.
Stevens KE; Zheng L; Floyd KL; Stitzel JA
Brain Res; 2015 Jun; 1611():8-17. PubMed ID: 25744161
[TBL] [Abstract][Full Text] [Related]
4. A humanized chemogenetic system inhibits murine pain-related behavior and hyperactivity in human sensory neurons.
Perez-Sanchez J; Middleton SJ; Pattison LA; Hilton H; Ali Awadelkareem M; Zuberi SR; Renke MB; Hu H; Yang X; Clark AJ; St John Smith E; Bennett DL
Sci Transl Med; 2023 Oct; 15(716):eadh3839. PubMed ID: 37792955
[TBL] [Abstract][Full Text] [Related]
5. The analgesic-like properties of the alpha7 nAChR silent agonist NS6740 is associated with non-conducting conformations of the receptor.
Papke RL; Bagdas D; Kulkarni AR; Gould T; AlSharari SD; Thakur GA; Damaj MI
Neuropharmacology; 2015 Apr; 91():34-42. PubMed ID: 25497451
[TBL] [Abstract][Full Text] [Related]
6. Identification and in vitro pharmacological characterization of a novel and selective α7 nicotinic acetylcholine receptor agonist, Br-IQ17B.
Tang JS; Xie BX; Bian XL; Xue Y; Wei NN; Zhou JH; Hao YC; Li G; Zhang LR; Wang KW
Acta Pharmacol Sin; 2015 Jul; 36(7):800-12. PubMed ID: 25948478
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.
Jackson A; Papke RL; Damaj MI
Psychopharmacology (Berl); 2018 Jul; 235(7):1897-1905. PubMed ID: 29549391
[TBL] [Abstract][Full Text] [Related]
8. Effects of BMS-902483, an α7 nicotinic acetylcholine receptor partial agonist, on cognition and sensory gating in relation to receptor occupancy in rodents.
Pieschl RL; Miller R; Jones KM; Post-Munson DJ; Chen P; Newberry K; Benitex Y; Molski T; Morgan D; McDonald IM; Macor JE; Olson RE; Asaka Y; Digavalli S; Easton A; Herrington J; Westphal RS; Lodge NJ; Zaczek R; Bristow LJ; Li YW
Eur J Pharmacol; 2017 Jul; 807():1-11. PubMed ID: 28438647
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholine receptor based chemogenetics engineered for neuronal inhibition and seizure control assessed in mice.
Nguyen QA; Klein PM; Xie C; Benthall KN; Iafrati J; Homidan J; Bendor JT; Dudok B; Farrell JS; Gschwind T; Porter CL; Keravala A; Dodson GS; Soltesz I
Nat Commun; 2024 Jan; 15(1):601. PubMed ID: 38238329
[TBL] [Abstract][Full Text] [Related]
10. Impact of modulation of the α7 nicotinic acetylcholine receptor on nicotine reward in the mouse conditioned place preference test.
Jackson A; Alkhlaif Y; Papke RL; Brunzell DH; Damaj MI
Psychopharmacology (Berl); 2019 Dec; 236(12):3593-3599. PubMed ID: 31302720
[TBL] [Abstract][Full Text] [Related]
11. Long-term improvements in sensory inhibition with gestational choline supplementation linked to α7 nicotinic receptors through studies in Chrna7 null mutation mice.
Stevens KE; Choo KS; Stitzel JA; Marks MJ; Adams CE
Brain Res; 2014 Mar; 1552():26-33. PubMed ID: 24462939
[TBL] [Abstract][Full Text] [Related]
12. Curcumin Acts as a Positive Allosteric Modulator of
El Nebrisi EG; Bagdas D; Toma W; Al Samri H; Brodzik A; Alkhlaif Y; Yang KS; Howarth FC; Damaj IM; Oz M
J Pharmacol Exp Ther; 2018 Apr; 365(1):190-200. PubMed ID: 29339457
[TBL] [Abstract][Full Text] [Related]
13. PNU-120596, a positive allosteric modulator of mammalian α7 nicotinic acetylcholine receptor, is a negative modulator of ligand-gated chloride-selective channels of the gastropod Lymnaea stagnalis.
Vulfius CA; Lebedev DS; Kryukova EV; Kudryavtsev DS; Kolbaev SN; Utkin YN; Tsetlin VI
J Neurochem; 2020 Nov; 155(3):274-284. PubMed ID: 32248535
[TBL] [Abstract][Full Text] [Related]
14. Allosterically Potentiated
Miller DR; Khoshbouei H; Garai S; Cantwell LN; Stokes C; Thakur G; Papke RL
Mol Pharmacol; 2020 Dec; 98(6):695-709. PubMed ID: 33020143
[TBL] [Abstract][Full Text] [Related]
15. In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model.
Freitas K; Negus SS; Carroll FI; Damaj MI
Br J Pharmacol; 2013 Jun; 169(3):567-79. PubMed ID: 23004024
[TBL] [Abstract][Full Text] [Related]
16. Heteromeric α7β2 Nicotinic Acetylcholine Receptors in the Brain.
Wu J; Liu Q; Tang P; Mikkelsen JD; Shen J; Whiteaker P; Yakel JL
Trends Pharmacol Sci; 2016 Jul; 37(7):562-574. PubMed ID: 27179601
[TBL] [Abstract][Full Text] [Related]
17. Activation of α7 nicotinic acetylcholine receptors protects astrocytes against oxidative stress-induced apoptosis: implications for Parkinson's disease.
Liu Y; Zeng X; Hui Y; Zhu C; Wu J; Taylor DH; Ji J; Fan W; Huang Z; Hu J
Neuropharmacology; 2015 Apr; 91():87-96. PubMed ID: 25486621
[TBL] [Abstract][Full Text] [Related]
18. Using an engineered glutamate-gated chloride channel to silence sensory neurons and treat neuropathic pain at the source.
Weir GA; Middleton SJ; Clark AJ; Daniel T; Khovanov N; McMahon SB; Bennett DL
Brain; 2017 Oct; 140(10):2570-2585. PubMed ID: 28969375
[TBL] [Abstract][Full Text] [Related]
19. Spinal activation of alpha7-nicotinic acetylcholine receptor attenuates posttraumatic stress disorder-related chronic pain via suppression of glial activation.
Sun R; Zhang W; Bo J; Zhang Z; Lei Y; Huo W; Liu Y; Ma Z; Gu X
Neuroscience; 2017 Mar; 344():243-254. PubMed ID: 28039041
[TBL] [Abstract][Full Text] [Related]
20. Combining CDP-choline and galantamine: Effects of a selective α7 nicotinic acetylcholine receptor agonist strategy on P50 sensory gating of speech sounds in healthy volunteers.
Choueiry J; Blais CM; Shah D; Smith D; Fisher D; Illivitsky V; Knott V
J Psychopharmacol; 2019 Jun; 33(6):688-699. PubMed ID: 30920339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
